/

BANB.SW

BACHEM NClosed

80.70−0.20 −0.25%CHF

Swiss · as of Oct 13, 11:30 ET · 15m delay

Open

80.25

Prev close

80.90

Day range

80.0081.30

52-week range

48.5284.10

Volume

54.33K0.51×

Mkt cap

6.05B

P/E ttm

40.76

Fwd P/E

26.20

EPS ttm

1.98

Div yield

1.12%

Earnings

Jul 30, 2026

From 52w high

−4.04%

Price Chart

Yahoo Finance · delayed

BANB.SWOct 12, 2026O 79.95H 81.10L 79.00C 80.90+0.85 (+1.06%)Vol 83.52K

SMA 5077.66
SMA 20070.72

1Y change +42.05% since Oct 13, 2025 close537 bars loadedTimes in Europe/ZurichDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

BANB.SW BACHEM N · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +2.08%
1 month: +5.13%
3 months: +8.74%
6 months: +15.90%
Year to date: +35.06%
1 year: +43.57%

Valuation & ownership

Market cap: 6.05B
Enterprise value: 6.21B
P/E (ttm): 40.76
Forward P/E: 26.20
PEG ratio: 0.61
Price / book: 4.19
Price / sales (ttm): 8.54
EV / EBITDA: 29.52
EPS (ttm): 1.98
EPS (forward): 3.08
Beta (5y monthly): 0.79
Dividend yield: 1.12%
Payout ratio: 45.45%
Shares outstanding: 74.94M
Float: 31.25M
Short % of float: —
Short ratio (days): —
Held by insiders: 0.25%
Held by institutions: 82.64%
Avg volume (3m): 106.93K
50-day average: 77.66
200-day average: 70.88
52-week change: +43.57%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 55.3
vs 50-day SMA: +4.17%
vs 200-day SMA: +14.39%
50 / 200-day trend: ▲ 50 above 200
MACD vs signal: ▼ below
ATR (14) % of price: 3.24%
Realised vol (20d, ann.): 27.5%
From 52-week high: −3.80%
From 52-week low: +66.74%

ANR

Analyst Consensus

10 analysts

Consensus

Buy

2.20 on a 1 (strong buy) – 5 (sell) scale

Mean target

84.30

+4.46% implied

Low 50.00Median 87.00High 110.00

Recommendation trend

Now6 / 3 / 1
1m ago / 3 /

DES

About BACHEM N

Yahoo Finance profile

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.

Sector: Healthcare
Industry: Biotechnology
Employees: 2,725
Headquarters: Bubendorf, Switzerland
Website: bachem.com
Officers: Dr. Anne-Kathrin Stoller Ph.D. Chief Executive Officer
Mr. Alain Schaffter Chief Financial Officer
Mr. Hans van Hees Chief Operations Officer
Mr. Michael Suter Vice President of Global Accounting

SEAS

Seasonality · BANB.SW

2007–2026 · monthly returns

Strongest month Mar +3.68%Weakest month Sep −2.62%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	16.9	-15.1	9.2	9.2	8.5	-1.6	-1.1	1.1	7.2	-0.4			+34.7%
2025	0.9	-0.9	-10.6	-2.8	2.6	12.3	19.4	-8.2	-7.9	-0.4	-11.0	15.5	+3.5%
2024	-10.5	20.3	23.4	-7.2	0.9	2.0	-4.1	2.7	-12.3	-4.0	-0.4	-15.0	−10.9%
2023	0.8	16.8	-2.7	6.2	-1.5	-18.4	3.0	2.9	-17.7	-3.5	-0.9	0.0	−18.6%
2022	-23.6	-0.2	-6.4	-16.0	-12.3	-11.8	-3.8	6.4	-7.6	14.4	26.3	-12.0	−44.2%
2021	-9.9	-3.5	17.7	14.4	6.5	11.0	9.5	11.7	6.7	2.9	-9.8	7.8	+81.0%
2020	11.6	-4.6	17.8	17.4	7.2	1.8	9.8	39.5	2.6	-5.4	0.3	6.5	+155.5%
2019	0.5	-1.8	9.3	6.1	-3.5	2.9	2.6	8.8	-0.8	5.3	-1.2	4.2	+36.3%
2018	-8.4	-7.1	-4.0	1.3	-0.9	3.6	7.0	-8.3	-2.2	-6.2	5.1	-8.2	−26.2%
2017	20.6	6.5	2.2	-0.1	1.1	-8.7	-2.0	8.6	-0.2	8.4	7.7	13.5	+70.5%
2016	0.1	2.8	11.0	8.0	15.8	6.8	-0.4	11.5	4.0	-3.5	-4.2	6.9	+74.0%
2015	-12.2	9.8	10.3	-3.2	2.2	0.9	-0.9	0.8	-2.7	-0.4	2.5	0.7	+5.9%
2014	2.2	-3.6	3.5	0.5	-2.8	1.7	1.6	-0.2	-0.7	-1.0	-0.8	1.0	+1.0%
2013	3.8	0.5	3.8	0.5	-0.4	1.0	9.3	7.5	-10.1	23.5	-6.7	0.0	+33.2%
2012	3.1	13.0	-0.3	-3.8	-0.8	-5.6	4.4	-4.1	10.1	-0.7	-10.2	8.8	+12.0%
2011	-1.2	2.0	-11.8	3.2	-6.6	-0.2	-12.3	-3.1	-5.5	5.9	-5.4	-15.6	−42.0%
2010	2.0	-2.5	5.2	-1.4	-0.7	-5.1	-1.3	-12.9	-0.4	1.3	-8.9	9.8	−15.6%
2009	-5.9	-14.2	-4.6	13.2	-1.1	-2.7	6.7	-1.4	-1.3	0.6	-7.8	2.1	−17.6%
2008	-9.1	5.7	1.1	2.2	0.0	-4.1	-0.7	1.7	-3.8	-5.6	-10.5	7.7	−15.9%
2007	0.9	1.6	4.9	2.3	2.3	-1.5	-1.8	-1.8	0.0	2.8	-5.0	-0.3	+4.0%

BANB.SW

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

BANB.SW

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About BACHEM N

Seasonality · BANB.SW

Insider Activity · BANB.SW

Congress Trades · BANB.SW

Investors Holding BANB.SW

Investors Holding BANB.SW

Congress Trades · BANB.SW

Insider Activity · BANB.SW

Seasonality · BANB.SW

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About BACHEM N

Financial Snapshot

Earnings & Dividends

News